Results 151 to 160 of about 5,544 (172)

2020 recommendations from the French Society of Rheumatology for the management of gout: Urate-lowering therapy

Joint Bone Spine, 2020
Tristan Pascart, Augustin Latourte, Gérard Chales   +2 more
exaly  

Safety of Urate-Lowering Therapies

Rheumatic Disease Clinics of North America, 2012
openaire   +1 more source

Clinical interventions to improve adherence to urate-lowering therapy in patients with gout: a systematic review

International Journal of Pharmacy Practice, 2022
Klarissa A Sinnappah, Sophie L Stocker, Dyfrig A Hughes   +2 more
exaly  

Effect modification by contextual factors of urate-lowering therapy on serum urate in people with gout: A systematic review with meta-regression analysis

Seminars in Arthritis and Rheumatism, 2022
Ritch Te Kampe, Sabrina Mai Nielsen, Ioana Hotea   +2 more
exaly  

Cardiovascular diseases in gout and urate-lowering therapy

Therapy, 2021
openaire   +1 more source

Efficacy and safety of urate-lowering therapy in people with kidney impairment: a GCAN-initiated literature review

Rheumatology Advances in Practice, 2021
Hamish Farquhar, Ana BEATRIZ Vargas-Santos, Huai Leng Pisaniello   +2 more
exaly  

When to Start Urate Lowering Therapy?

Egyptian Journal of Rheumatology and Clinical Immunology, 2015
openaire   +1 more source

UltraSound evaluation in follow-up of urate-lowering therapy in gout phase 2 (USEFUL-2): Duration of flare prophylaxis

Joint Bone Spine, 2020
Esther Ebstein, Pascal Richette, Gael Mouterde   +2 more
exaly  

Urate-Lowering Therapy

2017
openaire   +1 more source

Volumetric reduction and dissolution prediction of monosodium urate crystal during urate-lowering therapy – a study using dual-energy computed tomography

Modern Rheumatology, 2021
exaly